Company intelligence / Profile preview
Hypera Pharma
São Paulo, São Paulo, Brazilhypera.com.br ↗
- Ownership
- Public · HYPE3
- Employees
- ~9000
- Development stage
- Commercial
01
Overview
Market leader in OTC medicines in Brazil with strong presence across all pharmaceutical retail segments. Recently expanded into hospital/institutional markets with injectables and first biological drug. Acquired significant product portfolios from Sanofi and Boehringer Ingelheim. Operates Latin America’s largest pharma complex; produces hundreds of millions of units annually. No detailed clinical trial results published for individual programs—most products are established brands or generics.
- Therapeutic areas
- CardiovascularNeurologyInfectious Diseases
- Modalities
- Small molecules (OTC and prescription drugs)Biologics (e.g., Hyblut for thrombosis/embolism)Nutraceuticals and dermocosmeticsVitamins and supplements
- Industry
- Biotech
02
Drug pipeline
4 assets3 more assets in the full pipeline.
Request access →03
Partnerships
Boehringer Ingelheim – acquisition of scopolamine production assets & Buscopan manufacturing plantSanofi – acquisition of OTC/Rx portfolio in Brazil
Beyond the preview
Go deeper on Hypera Pharma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Hypera Pharma.